Global Radiopharmaceuticals in Nuclear Medicine Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Radiopharmaceuticals in Nuclear Medicine Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Radiopharmaceuticals in Nuclear Medicine by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Radiopharmaceuticals in Nuclear Medicine by Country/Region, 2017, 2022 & 2028

2.2 Radiopharmaceuticals in Nuclear Medicine Segment by Type

2.2.1 Diagnostic Radiopharmaceuticals

2.2.2 Therapy Radiopharmaceuticals

2.2.3 Enriched Stable Isotopes

2.3 Radiopharmaceuticals in Nuclear Medicine Sales by Type

2.3.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2017-2022)

2.3.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue and Market Share by Type (2017-2022)

2.3.3 Global Radiopharmaceuticals in Nuclear Medicine Sale Price by Type (2017-2022)

2.4 Radiopharmaceuticals in Nuclear Medicine Segment by Application

2.4.1 Diagnostic Application

2.4.2 Therapeutic Application

2.4.3 Research

2.4.4 Pharmaceutical

2.4.5 Other

2.5 Radiopharmaceuticals in Nuclear Medicine Sales by Application

2.5.1 Global Radiopharmaceuticals in Nuclear Medicine Sale Market Share by Application (2017-2022)

2.5.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue and Market Share by Application (2017-2022)

2.5.3 Global Radiopharmaceuticals in Nuclear Medicine Sale Price by Application (2017-2022)

3 Global Radiopharmaceuticals in Nuclear Medicine by Company

3.1 Global Radiopharmaceuticals in Nuclear Medicine Breakdown Data by Company

3.1.1 Global Radiopharmaceuticals in Nuclear Medicine Annual Sales by Company (2020-2022)

3.1.2 Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Company (2020-2022)

3.2 Global Radiopharmaceuticals in Nuclear Medicine Annual Revenue by Company (2020-2022)

3.2.1 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Company (2020-2022)

3.2.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Company (2020-2022)

3.3 Global Radiopharmaceuticals in Nuclear Medicine Sale Price by Company

3.4 Key Manufacturers Radiopharmaceuticals in Nuclear Medicine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Radiopharmaceuticals in Nuclear Medicine Product Location Distribution

3.4.2 Players Radiopharmaceuticals in Nuclear Medicine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Radiopharmaceuticals in Nuclear Medicine by Geographic Region

4.1 World Historic Radiopharmaceuticals in Nuclear Medicine Market Size by Geographic Region (2017-2022)

4.1.1 Global Radiopharmaceuticals in Nuclear Medicine Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Radiopharmaceuticals in Nuclear Medicine Annual Revenue by Geographic Region

4.2 World Historic Radiopharmaceuticals in Nuclear Medicine Market Size by Country/Region (2017-2022)

4.2.1 Global Radiopharmaceuticals in Nuclear Medicine Annual Sales by Country/Region (2017-2022)

4.2.2 Global Radiopharmaceuticals in Nuclear Medicine Annual Revenue by Country/Region

4.3 Americas Radiopharmaceuticals in Nuclear Medicine Sales Growth

4.4 APAC Radiopharmaceuticals in Nuclear Medicine Sales Growth

4.5 Europe Radiopharmaceuticals in Nuclear Medicine Sales Growth

4.6 Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Sales Growth

5 Americas

5.1 Americas Radiopharmaceuticals in Nuclear Medicine Sales by Country

5.1.1 Americas Radiopharmaceuticals in Nuclear Medicine Sales by Country (2017-2022)

5.1.2 Americas Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2017-2022)

5.2 Americas Radiopharmaceuticals in Nuclear Medicine Sales by Type

5.3 Americas Radiopharmaceuticals in Nuclear Medicine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Radiopharmaceuticals in Nuclear Medicine Sales by Region

6.1.1 APAC Radiopharmaceuticals in Nuclear Medicine Sales by Region (2017-2022)

6.1.2 APAC Radiopharmaceuticals in Nuclear Medicine Revenue by Region (2017-2022)

6.2 APAC Radiopharmaceuticals in Nuclear Medicine Sales by Type

6.3 APAC Radiopharmaceuticals in Nuclear Medicine Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Radiopharmaceuticals in Nuclear Medicine by Country

7.1.1 Europe Radiopharmaceuticals in Nuclear Medicine Sales by Country (2017-2022)

7.1.2 Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2017-2022)

7.2 Europe Radiopharmaceuticals in Nuclear Medicine Sales by Type

7.3 Europe Radiopharmaceuticals in Nuclear Medicine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Radiopharmaceuticals in Nuclear Medicine by Country

8.1.1 Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Sales by Country (2017-2022)

8.1.2 Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2017-2022)

8.2 Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Sales by Type

8.3 Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Radiopharmaceuticals in Nuclear Medicine

10.3 Manufacturing Process Analysis of Radiopharmaceuticals in Nuclear Medicine

10.4 Industry Chain Structure of Radiopharmaceuticals in Nuclear Medicine

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Radiopharmaceuticals in Nuclear Medicine Distributors

11.3 Radiopharmaceuticals in Nuclear Medicine Customer

12 World Forecast Review for Radiopharmaceuticals in Nuclear Medicine by Geographic Region

12.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size Forecast by Region

12.1.1 Global Radiopharmaceuticals in Nuclear Medicine Forecast by Region (2023-2028)

12.1.2 Global Radiopharmaceuticals in Nuclear Medicine Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Radiopharmaceuticals in Nuclear Medicine Forecast by Type

12.7 Global Radiopharmaceuticals in Nuclear Medicine Forecast by Application

13 Key Players Analysis

13.1 Bracco Imaging S.P.A.

13.1.1 Bracco Imaging S.P.A. Company Information

13.1.2 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Product Offered

13.1.3 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Bracco Imaging S.P.A. Main Business Overview

13.1.5 Bracco Imaging S.P.A. Latest Developments

13.2 Cambridge Isotope Laboratories, Inc.

13.2.1 Cambridge Isotope Laboratories, Inc. Company Information

13.2.2 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Product Offered

13.2.3 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Cambridge Isotope Laboratories, Inc. Main Business Overview

13.2.5 Cambridge Isotope Laboratories, Inc. Latest Developments

13.3 Cardinal Health, Inc.

13.3.1 Cardinal Health, Inc. Company Information

13.3.2 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Product Offered

13.3.3 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Cardinal Health, Inc. Main Business Overview

13.3.5 Cardinal Health, Inc. Latest Developments

13.4 Covidien, Plc

13.4.1 Covidien, Plc Company Information

13.4.2 Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Product Offered

13.4.3 Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Covidien, Plc Main Business Overview

13.4.5 Covidien, Plc Latest Developments

13.5 Eczacibasi-Monrol

13.5.1 Eczacibasi-Monrol Company Information

13.5.2 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Product Offered

13.5.3 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Eczacibasi-Monrol Main Business Overview

13.5.5 Eczacibasi-Monrol Latest Developments

13.6 Fujifilm Holdings Corporation

13.6.1 Fujifilm Holdings Corporation Company Information

13.6.2 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Product Offered

13.6.3 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Fujifilm Holdings Corporation Main Business Overview

13.6.5 Fujifilm Holdings Corporation Latest Developments

13.7 GE Healthcare (Subsidiary Of General Electric Company)

13.7.1 GE Healthcare (Subsidiary Of General Electric Company) Company Information

13.7.2 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Product Offered

13.7.3 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 GE Healthcare (Subsidiary Of General Electric Company) Main Business Overview

13.7.5 GE Healthcare (Subsidiary Of General Electric Company) Latest Developments

13.8 IBA Group

13.8.1 IBA Group Company Information

13.8.2 IBA Group Radiopharmaceuticals in Nuclear Medicine Product Offered

13.8.3 IBA Group Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 IBA Group Main Business Overview

13.8.5 IBA Group Latest Developments

13.9 Isotec, Inc. (Sigma-Aldrich)

13.9.1 Isotec, Inc. (Sigma-Aldrich) Company Information

13.9.2 Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Product Offered

13.9.3 Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Isotec, Inc. (Sigma-Aldrich) Main Business Overview

13.9.5 Isotec, Inc. (Sigma-Aldrich) Latest Developments

13.10 Lantheus Medical Imaging, Inc.

13.10.1 Lantheus Medical Imaging, Inc. Company Information

13.10.2 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Product Offered

13.10.3 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Lantheus Medical Imaging, Inc. Main Business Overview

13.10.5 Lantheus Medical Imaging, Inc. Latest Developments

13.11 Nordion, Inc.

13.11.1 Nordion, Inc. Company Information

13.11.2 Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Product Offered

13.11.3 Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Nordion, Inc. Main Business Overview

13.11.5 Nordion, Inc. Latest Developments

13.12 Ntp Radioisotopes (Pty), Ltd.

13.12.1 Ntp Radioisotopes (Pty), Ltd. Company Information

13.12.2 Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Product Offered

13.12.3 Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Ntp Radioisotopes (Pty), Ltd. Main Business Overview

13.12.5 Ntp Radioisotopes (Pty), Ltd. Latest Developments

13.13 Siemens Healthcare (Subsidiary Of Siemens AG)

13.13.1 Siemens Healthcare (Subsidiary Of Siemens AG) Company Information

13.13.2 Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Product Offered

13.13.3 Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Siemens Healthcare (Subsidiary Of Siemens AG) Main Business Overview

13.13.5 Siemens Healthcare (Subsidiary Of Siemens AG) Latest Developments

13.14 Taiyo Nippon Sanso Corporation

13.14.1 Taiyo Nippon Sanso Corporation Company Information

13.14.2 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Product Offered

13.14.3 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Taiyo Nippon Sanso Corporation Main Business Overview

13.14.5 Taiyo Nippon Sanso Corporation Latest Developments

13.15 Urenco Limited

13.15.1 Urenco Limited Company Information

13.15.2 Urenco Limited Radiopharmaceuticals in Nuclear Medicine Product Offered

13.15.3 Urenco Limited Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Urenco Limited Main Business Overview

13.15.5 Urenco Limited Latest Developments

13.16 Rotem Industries, Ltd., Inc.

13.16.1 Rotem Industries, Ltd., Inc. Company Information

13.16.2 Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Product Offered

13.16.3 Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Rotem Industries, Ltd., Inc. Main Business Overview

13.16.5 Rotem Industries, Ltd., Inc. Latest Developments

13.17 Australian Nuclear Association And Technology Organization (ANSTO)

13.17.1 Australian Nuclear Association And Technology Organization (ANSTO) Company Information

13.17.2 Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Product Offered

13.17.3 Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Australian Nuclear Association And Technology Organization (ANSTO) Main Business Overview

13.17.5 Australian Nuclear Association And Technology Organization (ANSTO) Latest Developments

13.18 Board of Radiation And Isotope Technology (BRIT)

13.18.1 Board of Radiation And Isotope Technology (BRIT) Company Information

13.18.2 Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Product Offered

13.18.3 Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Board of Radiation And Isotope Technology (BRIT) Main Business Overview

13.18.5 Board of Radiation And Isotope Technology (BRIT) Latest Developments

13.19 Institute of Atomic Energy Polatom Radioisotope Centre

13.19.1 Institute of Atomic Energy Polatom Radioisotope Centre Company Information

13.19.2 Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Product Offered

13.19.3 Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Institute of Atomic Energy Polatom Radioisotope Centre Main Business Overview

13.19.5 Institute of Atomic Energy Polatom Radioisotope Centre Latest Developments

13.20 Institute of Isotopes Co., Ltd.

13.20.1 Institute of Isotopes Co., Ltd. Company Information

13.20.2 Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Product Offered

13.20.3 Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 Institute of Isotopes Co., Ltd. Main Business Overview

13.20.5 Institute of Isotopes Co., Ltd. Latest Developments

13.21 Institute Of Radioelement (IRE)

13.21.1 Institute Of Radioelement (IRE) Company Information

13.21.2 Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Product Offered

13.21.3 Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin (2020-2022)

13.21.4 Institute Of Radioelement (IRE) Main Business Overview

13.21.5 Institute Of Radioelement (IRE) Latest Developments

14 Research Findings and Conclusion

Table 1. Radiopharmaceuticals in Nuclear Medicine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Radiopharmaceuticals in Nuclear Medicine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Diagnostic Radiopharmaceuticals

Table 4. Major Players of Therapy Radiopharmaceuticals

Table 5. Major Players of Enriched Stable Isotopes

Table 6. Global Radiopharmaceuticals in Nuclear Medicine Sales by Type (2017-2022) & (K MT)

Table 7. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2017-2022)

Table 8. Global Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2017-2022) & ($ million)

Table 9. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Type (2017-2022)

Table 10. Global Radiopharmaceuticals in Nuclear Medicine Sale Price by Type (2017-2022) & (USD/MT)

Table 11. Global Radiopharmaceuticals in Nuclear Medicine Sales by Application (2017-2022) & (K MT)

Table 12. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2017-2022)

Table 13. Global Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2017-2022)

Table 14. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Application (2017-2022)

Table 15. Global Radiopharmaceuticals in Nuclear Medicine Sale Price by Application (2017-2022) & (USD/MT)

Table 16. Global Radiopharmaceuticals in Nuclear Medicine Sales by Company (2020-2022) & (K MT)

Table 17. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Company (2020-2022)

Table 18. Global Radiopharmaceuticals in Nuclear Medicine Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Company (2020-2022)

Table 20. Global Radiopharmaceuticals in Nuclear Medicine Sale Price by Company (2020-2022) & (USD/MT)

Table 21. Key Manufacturers Radiopharmaceuticals in Nuclear Medicine Producing Area Distribution and Sales Area

Table 22. Players Radiopharmaceuticals in Nuclear Medicine Products Offered

Table 23. Radiopharmaceuticals in Nuclear Medicine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Radiopharmaceuticals in Nuclear Medicine Sales by Geographic Region (2017-2022) & (K MT)

Table 27. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share Geographic Region (2017-2022)

Table 28. Global Radiopharmaceuticals in Nuclear Medicine Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Radiopharmaceuticals in Nuclear Medicine Sales by Country/Region (2017-2022) & (K MT)

Table 31. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Country/Region (2017-2022)

Table 32. Global Radiopharmaceuticals in Nuclear Medicine Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Radiopharmaceuticals in Nuclear Medicine Sales by Country (2017-2022) & (K MT)

Table 35. Americas Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Country (2017-2022)

Table 36. Americas Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Country (2017-2022)

Table 38. Americas Radiopharmaceuticals in Nuclear Medicine Sales by Type (2017-2022) & (K MT)

Table 39. Americas Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2017-2022)

Table 40. Americas Radiopharmaceuticals in Nuclear Medicine Sales by Application (2017-2022) & (K MT)

Table 41. Americas Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2017-2022)

Table 42. APAC Radiopharmaceuticals in Nuclear Medicine Sales by Region (2017-2022) & (K MT)

Table 43. APAC Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Region (2017-2022)

Table 44. APAC Radiopharmaceuticals in Nuclear Medicine Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Region (2017-2022)

Table 46. APAC Radiopharmaceuticals in Nuclear Medicine Sales by Type (2017-2022) & (K MT)

Table 47. APAC Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2017-2022)

Table 48. APAC Radiopharmaceuticals in Nuclear Medicine Sales by Application (2017-2022) & (K MT)

Table 49. APAC Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2017-2022)

Table 50. Europe Radiopharmaceuticals in Nuclear Medicine Sales by Country (2017-2022) & (K MT)

Table 51. Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Country (2017-2022)

Table 52. Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Country (2017-2022)

Table 54. Europe Radiopharmaceuticals in Nuclear Medicine Sales by Type (2017-2022) & (K MT)

Table 55. Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2017-2022)

Table 56. Europe Radiopharmaceuticals in Nuclear Medicine Sales by Application (2017-2022) & (K MT)

Table 57. Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Sales by Country (2017-2022) & (K MT)

Table 59. Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Sales by Type (2017-2022) & (K MT)

Table 63. Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Sales by Application (2017-2022) & (K MT)

Table 65. Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Radiopharmaceuticals in Nuclear Medicine

Table 67. Key Market Challenges & Risks of Radiopharmaceuticals in Nuclear Medicine

Table 68. Key Industry Trends of Radiopharmaceuticals in Nuclear Medicine

Table 69. Radiopharmaceuticals in Nuclear Medicine Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Radiopharmaceuticals in Nuclear Medicine Distributors List

Table 72. Radiopharmaceuticals in Nuclear Medicine Customer List

Table 73. Global Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Region (2023-2028) & (K MT)

Table 74. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Forecast by Region

Table 75. Global Radiopharmaceuticals in Nuclear Medicine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Country (2023-2028) & (K MT)

Table 78. Americas Radiopharmaceuticals in Nuclear Medicine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Region (2023-2028) & (K MT)

Table 80. APAC Radiopharmaceuticals in Nuclear Medicine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Country (2023-2028) & (K MT)

Table 82. Europe Radiopharmaceuticals in Nuclear Medicine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Country (2023-2028) & (K MT)

Table 84. Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Type (2023-2028) & (K MT)

Table 86. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Radiopharmaceuticals in Nuclear Medicine Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Application (2023-2028) & (K MT)

Table 90. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Radiopharmaceuticals in Nuclear Medicine Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share Forecast by Application (2023-2028)

Table 93. Bracco Imaging S.P.A. Basic Information, Radiopharmaceuticals in Nuclear Medicine Manufacturing Base, Sales Area and Its Competitors

Table 94. Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Product Offered

Table 95. Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 96. Bracco Imaging S.P.A. Main Business

Table 97. Bracco Imaging S.P.A. Latest Developments

Table 98. Cambridge Isotope Laboratories, Inc. Basic Information, Radiopharmaceuticals in Nuclear Medicine Manufacturing Base, Sales Area and Its Competitors

Table 99. Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Product Offered

Table 100. Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 101. Cambridge Isotope Laboratories, Inc. Main Business

Table 102. Cambridge Isotope Laboratories, Inc. Latest Developments

Table 103. Cardinal Health, Inc. Basic Information, Radiopharmaceuticals in Nuclear Medicine Manufacturing Base, Sales Area and Its Competitors

Table 104. Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Product Offered

Table 105. Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 106. Cardinal Health, Inc. Main Business

Table 107. Cardinal Health, Inc. Latest Developments

Table 108. Covidien, Plc Basic Information, Radiopharmaceuticals in Nuclear Medicine Manufacturing Base, Sales Area and Its Competitors

Table 109. Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Product Offered

Table 110. Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 111. Covidien, Plc Main Business

Table 112. Covidien, Plc Latest Developments

Table 113. Eczacibasi-Monrol Basic Information, Radiopharmaceuticals in Nuclear Medicine Manufacturing Base, Sales Area and Its Competitors

Table 114. Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Product Offered

Table 115. Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 116. Eczacibasi-Monrol Main Business

Table 117. Eczacibasi-Monrol Latest Developments

Table 118. Fujifilm Holdings Corporation Basic Information, Radiopharmaceuticals in Nuclear Medicine Manufacturing Base, Sales Area and Its Competitors

Table 119. Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Product Offered

Table 120. Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 121. Fujifilm Holdings Corporation Main Business

Table 122. Fujifilm Holdings Corporation Latest Developments

Table 123. GE Healthcare (Subsidiary Of General Electric Company) Basic Information, Radiopharmaceuticals in Nuclear Medicine Manufacturing Base, Sales Area and Its Competitors

Table 124. GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Product Offered

Table 125. GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 126. GE Healthcare (Subsidiary Of General Electric Company) Main Business

Table 127. GE Healthcare (Subsidiary Of General Electric Company) Latest Developments

Table 128. IBA Group Basic Information, Radiopharmaceuticals in Nuclear Medicine Manufacturing Base, Sales Area and Its Competitors

Table 129. IBA Group Radiopharmaceuticals in Nuclear Medicine Product Offered

Table 130. IBA Group Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 131. IBA Group Main Business

Table 132. IBA Group Latest Developments

Table 133. Isotec, Inc. (Sigma-Aldrich) Basic Information, Radiopharmaceuticals in Nuclear Medicine Manufacturing Base, Sales Area and Its Competitors

Table 134. Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Product Offered

Table 135. Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 136. Isotec, Inc. (Sigma-Aldrich) Main Business

Table 137. Isotec, Inc. (Sigma-Aldrich) Latest Developments

Table 138. Lantheus Medical Imaging, Inc. Basic Information, Radiopharmaceuticals in Nuclear Medicine Manufacturing Base, Sales Area and Its Competitors

Table 139. Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Product Offered

Table 140. Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 141. Lantheus Medical Imaging, Inc. Main Business

Table 142. Lantheus Medical Imaging, Inc. Latest Developments

Table 143. Nordion, Inc. Basic Information, Radiopharmaceuticals in Nuclear Medicine Manufacturing Base, Sales Area and Its Competitors

Table 144. Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Product Offered

Table 145. Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 146. Nordion, Inc. Main Business

Table 147. Nordion, Inc. Latest Developments

Table 148. Ntp Radioisotopes (Pty), Ltd. Basic Information, Radiopharmaceuticals in Nuclear Medicine Manufacturing Base, Sales Area and Its Competitors

Table 149. Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Product Offered

Table 150. Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 151. Ntp Radioisotopes (Pty), Ltd. Main Business

Table 152. Ntp Radioisotopes (Pty), Ltd. Latest Developments

Table 153. Siemens Healthcare (Subsidiary Of Siemens AG) Basic Information, Radiopharmaceuticals in Nuclear Medicine Manufacturing Base, Sales Area and Its Competitors

Table 154. Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Product Offered

Table 155. Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 156. Siemens Healthcare (Subsidiary Of Siemens AG) Main Business

Table 157. Siemens Healthcare (Subsidiary Of Siemens AG) Latest Developments

Table 158. Taiyo Nippon Sanso Corporation Basic Information, Radiopharmaceuticals in Nuclear Medicine Manufacturing Base, Sales Area and Its Competitors

Table 159. Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Product Offered

Table 160. Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 161. Taiyo Nippon Sanso Corporation Main Business

Table 162. Taiyo Nippon Sanso Corporation Latest Developments

Table 163. Urenco Limited Basic Information, Radiopharmaceuticals in Nuclear Medicine Manufacturing Base, Sales Area and Its Competitors

Table 164. Urenco Limited Radiopharmaceuticals in Nuclear Medicine Product Offered

Table 165. Urenco Limited Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 166. Urenco Limited Main Business

Table 167. Urenco Limited Latest Developments

Table 168. Rotem Industries, Ltd., Inc. Basic Information, Radiopharmaceuticals in Nuclear Medicine Manufacturing Base, Sales Area and Its Competitors

Table 169. Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Product Offered

Table 170. Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 171. Rotem Industries, Ltd., Inc. Main Business

Table 172. Rotem Industries, Ltd., Inc. Latest Developments

Table 173. Australian Nuclear Association And Technology Organization (ANSTO) Basic Information, Radiopharmaceuticals in Nuclear Medicine Manufacturing Base, Sales Area and Its Competitors

Table 174. Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Product Offered

Table 175. Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 176. Australian Nuclear Association And Technology Organization (ANSTO) Main Business

Table 177. Australian Nuclear Association And Technology Organization (ANSTO) Latest Developments

Table 178. Board of Radiation And Isotope Technology (BRIT) Basic Information, Radiopharmaceuticals in Nuclear Medicine Manufacturing Base, Sales Area and Its Competitors

Table 179. Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Product Offered

Table 180. Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 181. Board of Radiation And Isotope Technology (BRIT) Main Business

Table 182. Board of Radiation And Isotope Technology (BRIT) Latest Developments

Table 183. Institute of Atomic Energy Polatom Radioisotope Centre Basic Information, Radiopharmaceuticals in Nuclear Medicine Manufacturing Base, Sales Area and Its Competitors

Table 184. Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Product Offered

Table 185. Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 186. Institute of Atomic Energy Polatom Radioisotope Centre Main Business

Table 187. Institute of Atomic Energy Polatom Radioisotope Centre Latest Developments

Table 188. Institute of Isotopes Co., Ltd. Basic Information, Radiopharmaceuticals in Nuclear Medicine Manufacturing Base, Sales Area and Its Competitors

Table 189. Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Product Offered

Table 190. Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 191. Institute of Isotopes Co., Ltd. Main Business

Table 192. Institute of Isotopes Co., Ltd. Latest Developments

Table 193. Institute Of Radioelement (IRE) Basic Information, Radiopharmaceuticals in Nuclear Medicine Manufacturing Base, Sales Area and Its Competitors

Table 194. Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Product Offered

Table 195. Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 196. Institute Of Radioelement (IRE) Main Business

Table 197. Institute Of Radioelement (IRE) Latest Developments

List of Figures

Figure 1. Picture of Radiopharmaceuticals in Nuclear Medicine

Figure 2. Radiopharmaceuticals in Nuclear Medicine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate 2017-2028 (K MT)

Figure 7. Global Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Radiopharmaceuticals in Nuclear Medicine Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Diagnostic Radiopharmaceuticals

Figure 10. Product Picture of Therapy Radiopharmaceuticals

Figure 11. Product Picture of Enriched Stable Isotopes

Figure 12. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type in 2021

Figure 13. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Type (2017-2022)

Figure 14. Radiopharmaceuticals in Nuclear Medicine Consumed in Diagnostic Application

Figure 15. Global Radiopharmaceuticals in Nuclear Medicine Market: Diagnostic Application (2017-2022) & (K MT)

Figure 16. Radiopharmaceuticals in Nuclear Medicine Consumed in Therapeutic Application

Figure 17. Global Radiopharmaceuticals in Nuclear Medicine Market: Therapeutic Application (2017-2022) & (K MT)

Figure 18. Radiopharmaceuticals in Nuclear Medicine Consumed in Research

Figure 19. Global Radiopharmaceuticals in Nuclear Medicine Market: Research (2017-2022) & (K MT)

Figure 20. Radiopharmaceuticals in Nuclear Medicine Consumed in Pharmaceutical

Figure 21. Global Radiopharmaceuticals in Nuclear Medicine Market: Pharmaceutical (2017-2022) & (K MT)

Figure 22. Radiopharmaceuticals in Nuclear Medicine Consumed in Other

Figure 23. Global Radiopharmaceuticals in Nuclear Medicine Market: Other (2017-2022) & (K MT)

Figure 24. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2017-2022)

Figure 25. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Application in 2021

Figure 26. Radiopharmaceuticals in Nuclear Medicine Revenue Market by Company in 2021 ($ Million)

Figure 27. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Company in 2021

Figure 28. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Geographic Region (2017-2022)

Figure 29. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Geographic Region in 2021

Figure 30. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Region (2017-2022)

Figure 31. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Country/Region in 2021

Figure 32. Americas Radiopharmaceuticals in Nuclear Medicine Sales 2017-2022 (K MT)

Figure 33. Americas Radiopharmaceuticals in Nuclear Medicine Revenue 2017-2022 ($ Millions)

Figure 34. APAC Radiopharmaceuticals in Nuclear Medicine Sales 2017-2022 (K MT)

Figure 35. APAC Radiopharmaceuticals in Nuclear Medicine Revenue 2017-2022 ($ Millions)

Figure 36. Europe Radiopharmaceuticals in Nuclear Medicine Sales 2017-2022 (K MT)

Figure 37. Europe Radiopharmaceuticals in Nuclear Medicine Revenue 2017-2022 ($ Millions)

Figure 38. Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Sales 2017-2022 (K MT)

Figure 39. Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Revenue 2017-2022 ($ Millions)

Figure 40. Americas Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Country in 2021

Figure 41. Americas Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Country in 2021

Figure 42. United States Radiopharmaceuticals in Nuclear Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 43. Canada Radiopharmaceuticals in Nuclear Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 44. Mexico Radiopharmaceuticals in Nuclear Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 45. Brazil Radiopharmaceuticals in Nuclear Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 46. APAC Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Region in 2021

Figure 47. APAC Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Regions in 2021

Figure 48. China Radiopharmaceuticals in Nuclear Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 49. Japan Radiopharmaceuticals in Nuclear Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 50. South Korea Radiopharmaceuticals in Nuclear Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 51. Southeast Asia Radiopharmaceuticals in Nuclear Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 52. India Radiopharmaceuticals in Nuclear Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 53. Australia Radiopharmaceuticals in Nuclear Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 54. Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Country in 2021

Figure 55. Europe Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Country in 2021

Figure 56. Germany Radiopharmaceuticals in Nuclear Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 57. France Radiopharmaceuticals in Nuclear Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 58. UK Radiopharmaceuticals in Nuclear Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 59. Italy Radiopharmaceuticals in Nuclear Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 60. Russia Radiopharmaceuticals in Nuclear Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 61. Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Country in 2021

Figure 62. Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Country in 2021

Figure 63. Egypt Radiopharmaceuticals in Nuclear Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 64. South Africa Radiopharmaceuticals in Nuclear Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 65. Israel Radiopharmaceuticals in Nuclear Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 66. Turkey Radiopharmaceuticals in Nuclear Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 67. GCC Country Radiopharmaceuticals in Nuclear Medicine Revenue Growth 2017-2022 ($ Millions)

Figure 68. Manufacturing Cost Structure Analysis of Radiopharmaceuticals in Nuclear Medicine in 2021

Figure 69. Manufacturing Process Analysis of Radiopharmaceuticals in Nuclear Medicine

Figure 70. Industry Chain Structure of Radiopharmaceuticals in Nuclear Medicine

Figure 71. Channels of Distribution

Figure 72. Distributors Profiles